WorldQuant Millennium Advisors’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-270,554
Closed -$21.7M 730
2026
Q1
$21.7M Sell
270,554
-182,012
-40% -$15M 0.08% 214
2025
Q4
$38.6M Buy
+452,566
New +$37.1M 0.15% 157
2025
Q3
Sell
-336,507
Closed -$26.3M 553
2025
Q2
$26.3M Sell
336,507
-25,692
-7% -$1.92M 0.13% 178
2025
Q1
$26.3M Sell
362,199
-363,805
-50% -$26M 0.17% 159
2024
Q4
$53.7M Buy
726,004
+125,487
+21% +$8.78M 0.35% 83
2024
Q3
$39.6M Buy
+600,517
New +$43.6M 0.29% 101
2024
Q1
Sell
-14,925
Closed -$1.14M 371
2023
Q4
$1.14M Sell
14,925
-140,957
-90% -$9.81M 0.02% 293
2023
Q3
$10.8M Sell
155,882
-256,530
-62% -$20.6M 0.17% 165
2023
Q2
$38.9M Sell
412,412
-90,199
-18% -$7.84M 0.66% 33
2023
Q1
$41.6M Sell
502,611
-503,893
-50% -$39.6M 0.77% 27
2022
Q4
$75.1M Buy
1,006,504
+451,823
+81% +$34.8M 1.71% 2
2022
Q3
$45.8M Buy
554,681
+499,104
+898% +$48M 1.11% 17
2022
Q2
$5.29M Sell
55,577
-13,309
-19% -$1.38M 0.15% 183
2022
Q1
$8.11M Sell
68,886
-28,978
-30% -$3.25M 0.2% 164
2021
Q4
$12.7M Buy
97,864
+73,821
+307% +$8.61M 0.25% 135
2021
Q3
$2.72M Buy
+24,043
New +$2.74M 0.06% 245
2021
Q2
Sell
-77,292
Closed -$6.46M 359
2021
Q1
$6.46M Hold
77,292
0.14% 207
2020
Q4
$7.05M Sell
77,292
-25,547
-25% -$2.12M 0.15% 200
2020
Q3
$8.21M Sell
102,839
-80,468
-44% -$6.28M 0.19% 158
2020
Q2
$12.7M Sell
183,307
-19,769
-10% -$1.4M 0.29% 115
2020
Q1
$12.8M Buy
+203,076
New +$14.6M 0.31% 108
2018
Q4
Sell
-52,878
Closed -$3.07M 314
2018
Q3
$3.07M Buy
52,878
+1,770
+3% +$86.6K 0.1% 186
2018
Q2
$2.48M Buy
+51,108
New +$2.39M 0.1% 190

Other funds holding EW

WorldQuant Millennium Advisors's EW Position: Q2 2026 in Review

WorldQuant Millennium Advisors sold out of Edwards Lifesciences (EW) in Q2 2026, closing a stake of 270,554 shares — an estimated $21.7M sold.

WorldQuant Millennium Advisors first reported a position in EW in Q2 2018 and held it in 23 quarters. The position peaked at $75.1M in Q4 2022. 1,333 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • WorldQuant Millennium Advisors reported no remaining Edwards Lifesciences position as of Q2 2026 after selling out during the quarter.
  • WorldQuant Millennium Advisors sold 270,554 Edwards Lifesciences shares in Q2 2026, an estimated $21.7M.
  • WorldQuant Millennium Advisors first reported a position in Edwards Lifesciences in Q2 2018 and held it in 23 quarters.
  • WorldQuant Millennium Advisors's Edwards Lifesciences position peaked at $75.1M in Q4 2022.
  • 1,333 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on WorldQuant Millennium Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.